Alcon AG | ALC - Operating Expenses



Alcon AG reported $2.35B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
AstraZeneca USD 10.95B 1.04B Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Essilor EUR 12.02B 308M Jun/2025
Fresenius EUR 5.02B 57M Jun/2025
Fresenius Medical Care EUR 4.36B 189M Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
GRIFOLS EUR 1.54B 24.64M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.22B 49M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Philips EUR 3.85B 93M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Sanofi EUR 9.02B 702M Jun/2025
Smith & Nephew USD 2.52B 133M Jun/2025
Sonova Holding CHF 1.55B 44.4M Sep/2024
UCB EUR 2.36B 108M Dec/2024